222 related articles for article (PubMed ID: 11245210)
1. Effect of NGF and neurotrophin-3 treatment on experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Escandon E
J Neuropathol Exp Neurol; 2001 Mar; 60(3):263-73. PubMed ID: 11245210
[TBL] [Abstract][Full Text] [Related]
2. Experimental rat models of types 1 and 2 diabetes differ in sympathetic neuroaxonal dystrophy.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Zhang W; Sima AA
J Neuropathol Exp Neurol; 2004 May; 63(5):450-60. PubMed ID: 15198124
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Yarasheski KE; Smith SR; Lang HJ; Williamson JR; Ido Y
J Neuropathol Exp Neurol; 2001 Dec; 60(12):1153-69. PubMed ID: 11764088
[TBL] [Abstract][Full Text] [Related]
4. Effect of streptozotocin-induced diabetes on NGF, P75(NTR) and TrkA content of prevertebral and paravertebral rat sympathetic ganglia.
Schmidt RE; Dorsey DA; Roth KA; Parvin CA; Hounsom L; Tomlinson DR
Brain Res; 2000 Jun; 867(1-2):149-56. PubMed ID: 10837808
[TBL] [Abstract][Full Text] [Related]
5. Effect of chronic autoimmune nerve growth factor deprivation on sympathetic neuroaxonal dystrophy in rats.
Schroer JA; Beaudet LN; Schmidt RE
Synapse; 1995 Jul; 20(3):249-56. PubMed ID: 7570357
[TBL] [Abstract][Full Text] [Related]
6. Effect of aminoguanidine on the frequency of neuroaxonal dystrophy in the superior mesenteric sympathetic autonomic ganglia of rats with streptozocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Reiser KM; Williamson JR; Tilton RG
Diabetes; 1996 Mar; 45(3):284-90. PubMed ID: 8593931
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Zucker Diabetic Fatty (ZDF) type 2 diabetic rat model suggests a neurotrophic role for insulin/IGF-I in diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Peterson RG
Am J Pathol; 2003 Jul; 163(1):21-8. PubMed ID: 12819007
[TBL] [Abstract][Full Text] [Related]
8. A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes.
Schmidt RE; Dorsey DA; Beaudet LN; Parvin CA; Yarasheski KE; Smith SR; Williamson JR; Peterson RG; Oates PJ
Exp Neurol; 2005 Apr; 192(2):407-19. PubMed ID: 15755558
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I reverses experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Miller MS
Am J Pathol; 1999 Nov; 155(5):1651-60. PubMed ID: 10550321
[TBL] [Abstract][Full Text] [Related]
10. NGF protects paravertebral but not prevertebral sympathetic neurons against exposure to high glucose in vitro.
Semra YK; Sherif S; Lincoln J
Brain Res; 2009 Aug; 1285():164-73. PubMed ID: 19505442
[TBL] [Abstract][Full Text] [Related]
11. Streptozotocin-induced diabetes causes metabolic changes and alterations in neurotrophin content and retrograde transport in the cervical vagus nerve.
Lee PG; Hohman TC; Cai F; Regalia J; Helke CJ
Exp Neurol; 2001 Jul; 170(1):149-61. PubMed ID: 11421592
[TBL] [Abstract][Full Text] [Related]
12. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Williamson JR; Ido Y
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1175-89. PubMed ID: 9862641
[TBL] [Abstract][Full Text] [Related]
13. The effect of pancreatic islet transplantation and insulin therapy on neuroaxonal dystrophy in sympathetic autonomic ganglia of chronic streptozocin-diabetic rats.
Schmidt RE; Plurad SB; Olack BJ; Scharp DW
Brain Res; 1989 Sep; 497(2):393-8. PubMed ID: 2510903
[TBL] [Abstract][Full Text] [Related]
14. Neuropathology and pathogenesis of diabetic autonomic neuropathy.
Schmidt RE
Int Rev Neurobiol; 2002; 50():257-92. PubMed ID: 12198813
[TBL] [Abstract][Full Text] [Related]
15. Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy.
Carroll SL; Byer SJ; Dorsey DA; Watson MA; Schmidt RE
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1144-54. PubMed ID: 15581182
[TBL] [Abstract][Full Text] [Related]
16. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy.
Schmidt RE; Dorsey DA; Beaudet LN; Frederick KE; Parvin CA; Plurad SB; Levisetti MG
Am J Pathol; 2003 Nov; 163(5):2077-91. PubMed ID: 14578206
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural and immunohistochemical characterization of autonomic neuropathy in genetically diabetic Chinese hamsters.
Schmidt RE; Plurad DA; Plurad SB; Cogswell BE; Diani AR; Roth KA
Lab Invest; 1989 Jul; 61(1):77-92. PubMed ID: 2747219
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural and biochemical characterization of autonomic neuropathy in rats with chronic streptozotocin diabetes.
Schmidt RE; Plurad SB
J Neuropathol Exp Neurol; 1986 Sep; 45(5):525-44. PubMed ID: 3746343
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice.
Schmidt RE; Green KG; Feng D; Dorsey DA; Parvin CA; Lee JM; Xiao Q; Brines M
Exp Neurol; 2008 Jan; 209(1):161-70. PubMed ID: 17967455
[TBL] [Abstract][Full Text] [Related]
20. The effects of deafferentation and exogenous NGF on neurotrophins and neurotrophin receptor mRNA expression in the adult superior cervical ganglion.
DeCouto SA; Jones EE; Kudwa AE; Shoemaker SE; Shafer AJ; Brieschke MA; James PF; Vaughn JC; Isaacson LG
Brain Res Mol Brain Res; 2003 Nov; 119(1):73-82. PubMed ID: 14597231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
